HHS criticizes research centers for inaction on patient safety

Article Abstract:

This article discusses the report from the Office of the Inspector General of the Department of Health and Human Services on patient safety in clinical research studies. The report finds that many of the institutions have failed to meet recommended changes in providing protection for patients; however, some clinics believe the recommendations to be unrealistic and cost prohibitive.

Care and treatment, Management, Reports, Medical research, Patients, Patient care, United States. Department of Health and Human Services

---

FDA tightens human oversight

Article Abstract:

The author discussed the protection of the human research subjects in the United States. The establishment of the Office for Human Research Trials by the Food and Drug Administration which coordinates the agency's monitoring clinical trials of new therapies and devices is analyzed.

United States. Food and Drug Administration

---

Stem cell researchers ponder worst-case scenario

Article Abstract:

The scientists have begun to dread the impact of a potential ban on federal funding for human embryonic stem cell research in the United States. This ban on federal funding for human cell work would raise serious problems for scientists and might criminalize developmental biology since, a lab using private funding for stem cell research would risk breaking the law by transferring stem cell DNA or RNA to cells in federally-funded projects.

Research and Development in the Physical, Engineering, and Life Sciences, Science & research, Scientists, Negotiation, mediation and arbitration, Stem cells

Similar abstracts:

• Abstracts: A Capitol idea: visitor center puts construction safety first. Power struggle
• Abstracts: A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. The role of transjugular portosystemic shunting in patients with ascites
• Abstracts: Gamma secretase-medicated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Activin to the rescue for overexcited neurons
• Abstracts: Researchers and regulators reflect on first gene therapy death. NIH researchers receive cut-price BRCA test

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.